Search
Search Results
##search.searchResults.foundPlural##
-
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4408PDF: 1780HTML: 1111 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3328PDF: 956HTML: 2968 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3701PDF: 908HTML: 6724 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1416HTML: 480PDF: 841 -
Can Polycythemia Vera evolve from Acute Myeloid Leukemia? A Case Report Showing a Simultaneous Minor JAK2 V617F Mutated Clone, De novo polycythemia vera following AML remission
1706PDF: 791HTML: 266 -
THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition
1398PDF: 859HTML: 140 -
The venetoclax/azacitidine combination targets the disease clone in Acute Myeloid Leukemia, being effective and safe in a patient with COVID VEN/AZA effectively targets AML clones
1295PDF: 778HTML: 321 -
-
BONE MARROW MICROENVIRONMENT INVOLVEMENT IN T-MN: FOCUS ON MESENCHYMAL STEM CELLS MESENCHYMAL STEM CELL IN T-MN
1836PDF: 1000HTML: 147 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2002PDF: 825HTML: 703
1 - 14 of 14 items







